Publications found:
58,333
Sort by:
Thymic Carcinoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF THYMIC CARCINOMA PIPELINE REPORT INCLUDES Panorama of Thymic Carcinoma pipeline markets including statistics on therapeutic drugs and companies involved Thymic Carcinoma Pipeline candidates across various development ...
August 2018
70 pages
Tinea pedis (Athlete Foot) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF TINEA PEDIS (ATHLETE FOOT) PIPELINE REPORT INCLUDES Panorama of Tinea pedis (Athlete Foot) pipeline markets including statistics on therapeutic drugs and companies involved Tinea pedis (Athlete Foot) Pipeline candidates across ...
August 2018
30 pages
Tinnitus R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF TINNITUS PIPELINE REPORT INCLUDES Panorama of Tinnitus pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Tourette Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF TOURETTE SYNDROME PIPELINE REPORT INCLUDES Panorama of Tourette Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Tourette Syndrome Pipeline candidates across various development ...
August 2018
70 pages
Toxoplasmosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF TOXOPLASMOSIS PIPELINE REPORT INCLUDES Panorama of Toxoplasmosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Traveler’s Diarrhea R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF TRAVELER’S DIARRHEA PIPELINE REPORT INCLUDES Panorama of Traveler’s Diarrhea pipeline markets including statistics on therapeutic drugs and companies involved Traveler’s Diarrhea Pipeline candidates across various development ...
August 2018
40 pages
Trigeminal Neuralgia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF TRIGEMINAL NEURALGIA PIPELINE REPORT INCLUDES Panorama of Trigeminal Neuralgia pipeline markets including statistics on therapeutic drugs and companies involved Trigeminal Neuralgia Pipeline candidates across various development ...
August 2018
40 pages
Tularaemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF TULARAEMIA PIPELINE REPORT INCLUDES Panorama of Tularaemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Typhoid Fever R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF TYPHOID FEVER PIPELINE REPORT INCLUDES Panorama of Typhoid Fever pipeline markets including statistics on therapeutic drugs and companies involved Typhoid Fever Pipeline candidates across various development ...
August 2018
40 pages
Ureter Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF URETER CANCER PIPELINE REPORT INCLUDES Panorama of Ureter Cancer pipeline markets including statistics on therapeutic drugs and companies involved Ureter Cancer Pipeline candidates across various development ...
August 2018
120 pages
Urinary Incontinence R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF URINARY INCONTINENCE PIPELINE REPORT INCLUDES Panorama of Urinary Incontinence pipeline markets including statistics on therapeutic drugs and companies involved Urinary Incontinence Pipeline candidates across various development ...
August 2018
60 pages
Usher Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF USHER SYNDROME PIPELINE REPORT INCLUDES Panorama of Usher Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Usher Syndrome Pipeline candidates across various development ...
August 2018
30 pages
Uterine Leiomyoma (Uterine Fibroids) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF UTERINE LEIOMYOMA (UTERINE FIBROIDS) PIPELINE REPORT INCLUDES Panorama of Uterine Leiomyoma (Uterine Fibroids) pipeline markets including statistics on therapeutic drugs and companies involved Uterine Leiomyoma (Uterine Fibroids) Pipeline candidates across ...
August 2018
80 pages
Uveal Melanoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF UVEAL MELANOMA PIPELINE REPORT INCLUDES Panorama of Uveal Melanoma pipeline markets including statistics on therapeutic drugs and companies involved Uveal Melanoma Pipeline candidates across various development ...
August 2018
150 pages
Uveitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF UVEITIS PIPELINE REPORT INCLUDES Panorama of Uveitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
160 pages
Vaginal Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VAGINAL CANCER PIPELINE REPORT INCLUDES Panorama of Vaginal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Vaginal Cancer Pipeline candidates across various development ...
August 2018
100 pages
Varicella Zoster Infection (HHV-3) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF VARICELLA ZOSTER INFECTION (HHV-3) PIPELINE REPORT INCLUDES Panorama of Varicella Zoster Infection (HHV-3) pipeline markets including statistics on therapeutic drugs and companies involved Varicella Zoster Infection (HHV-3) Pipeline candidates across ...
August 2018
80 pages
Vasculitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF VASCULITIS PIPELINE REPORT INCLUDES Panorama of Vasculitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
80 pages
Venous Leg Ulcers (Crural ulcer) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF VENOUS LEG ULCERS (CRURAL ULCER) PIPELINE REPORT INCLUDES Panorama of Venous Leg Ulcers (Crural ulcer) pipeline markets including statistics on therapeutic drugs and companies involved Venous Leg Ulcers (Crural ulcer) Pipeline candidates across ...
August 2018
50 pages
Ventilator Associated Pneumonia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VENTILATOR ASSOCIATED PNEUMONIA PIPELINE REPORT INCLUDES Panorama of Ventilator Associated Pneumonia pipeline markets including statistics on therapeutic drugs and companies involved Ventilator Associated Pneumonia Pipeline candidates across various development ...
August 2018
110 pages
Ventricular Tachycardia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VENTRICULAR TACHYCARDIA PIPELINE REPORT INCLUDES Panorama of Ventricular Tachycardia pipeline markets including statistics on therapeutic drugs and companies involved Ventricular Tachycardia Pipeline candidates across various development ...
August 2018
40 pages
Viral Conjunctivitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VIRAL CONJUNCTIVITIS PIPELINE REPORT INCLUDES Panorama of Viral Conjunctivitis pipeline markets including statistics on therapeutic drugs and companies involved Viral Conjunctivitis Pipeline candidates across various development ...
August 2018
30 pages
Visceral Pain R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VISCERAL PAIN PIPELINE REPORT INCLUDES Panorama of Visceral Pain pipeline markets including statistics on therapeutic drugs and companies involved Visceral Pain Pipeline candidates across various development ...
August 2018
40 pages
Vitiligo R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF VITILIGO PIPELINE REPORT INCLUDES Panorama of Vitiligo pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
70 pages
VRSA Infection R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VRSA INFECTION PIPELINE REPORT INCLUDES Panorama of VRSA Infection pipeline markets including statistics on therapeutic drugs and companies involved VRSA Infection Pipeline candidates across various development ...
August 2018
40 pages
Vulvar Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VULVAR CANCER PIPELINE REPORT INCLUDES Panorama of Vulvar Cancer pipeline markets including statistics on therapeutic drugs and companies involved Vulvar Cancer Pipeline candidates across various development ...
August 2018
100 pages
Vulvovaginal Candidiasis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF VULVOVAGINAL CANDIDIASIS PIPELINE REPORT INCLUDES Panorama of Vulvovaginal Candidiasis pipeline markets including statistics on therapeutic drugs and companies involved Vulvovaginal Candidiasis Pipeline candidates across various development ...
August 2018
50 pages
Waldenstrom Macroglobulinemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF WALDENSTROM MACROGLOBULINEMIA PIPELINE REPORT INCLUDES Panorama of Waldenstrom Macroglobulinemia pipeline markets including statistics on therapeutic drugs and companies involved Waldenstrom Macroglobulinemia Pipeline candidates across various development ...
August 2018
160 pages
Wegener Polyangiitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF WEGENER POLYANGIITIS PIPELINE REPORT INCLUDES Panorama of Wegener Polyangiitis pipeline markets including statistics on therapeutic drugs and companies involved Wegener Polyangiitis Pipeline candidates across various development ...
August 2018
50 pages
West Nile Virus Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF WEST NILE VIRUS INFECTIONS PIPELINE REPORT INCLUDES Panorama of West Nile Virus Infections pipeline markets including statistics on therapeutic drugs and companies involved West Nile Virus Infections Pipeline candidates across ...
August 2018
50 pages
Western Equine Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF WESTERN EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Western Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Western Equine Encephalitis Pipeline candidates across various development ...
August 2018
20 pages
Wilson Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF WILSON DISEASE PIPELINE REPORT INCLUDES Panorama of Wilson Disease pipeline markets including statistics on therapeutic drugs and companies involved Wilson Disease Pipeline candidates across various development ...
August 2018
40 pages
Women Infertility R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF WOMEN INFERTILITY PIPELINE REPORT INCLUDES Panorama of Women Infertility pipeline markets including statistics on therapeutic drugs and companies involved Women Infertility Pipeline candidates across various development ...
August 2018
150 pages
Xerostomia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF XEROSTOMIA PIPELINE REPORT INCLUDES Panorama of Xerostomia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Yellow Fever R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF YELLOW FEVER PIPELINE REPORT INCLUDES Panorama of Yellow Fever pipeline markets including statistics on therapeutic drugs and companies involved Yellow Fever Pipeline candidates across various development ...
August 2018
40 pages
Aspergillosis Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Aspergillosis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Aspergillosis pipeline products. DISEASE OVERVIEW Aspergillus is a general fungus type that causes ...
August 2018
90 pages
Burkholderia pseudomallei Infection Drug Development Pipeline Study, H2 2018
US$ 1,080.00
... is the main challenge in detecting and treating Burkholderia Infections disease. Individuals with low immunity levels and ... Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Burkholderia ...
August 2018
45 pages
Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chagas Disease (American trypanosomiasis) pipeline products. DISEASE OVERVIEW Chagas disease, also known as American Trypanosomiasis, is one of the ...
August 2018
70 pages
Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chikungunya (CHIKV) Infection pipeline products. DISEASE OVERVIEW Chikungunya fever is a viral fever, caused ...
August 2018
90 pages
Chlamydia Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Chlamydia Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chlamydia pipeline products. DISEASE OVERVIEW Chlamydia infections are caused by Chlamydia trachomatis bacteria. Worldwide, the ...
August 2018
60 pages
Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cryptosporidiosis (crypto) pipeline products. DISEASE OVERVIEW Cryptosporidium is one of the most widespread intestinal ...
August 2018
30 pages
Diphtheria Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Diphtheria Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Diphtheria pipeline products. DISEASE OVERVIEW Global Diphtheria market is estimated to be around $4.5 billion in 2020 driven ...
August 2018
60 pages
Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis A (HAV) Infection pipeline products. DISEASE OVERVIEW The disease is primarily ...
August 2018
35 pages
Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis D (HDV) pipeline products. DISEASE OVERVIEW Hepatitis D virus (HDV) infection is a liver disease ...
August 2018
50 pages
Herpes Labialis Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Herpes Labialis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Herpes Labialis pipeline products. DISEASE OVERVIEW Herpes Labialis referred to as cold sores, is a widespread infection impacting ...
August 2018
35 pages
Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018
US$ 1,080.00
Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Japanese Encephalitis (JEV) Infection pipeline products. DISEASE OVERVIEW Japanese encephalitis virus or JAVEX is a viral ...
August 2018
40 pages
